The Single Largest USDA Certified Organic Hemp Farm in North America
A Vertically Integrated Hemp Company, Devoted to Preserving and Promoting the Health of Individuals, Communities, and the Planet
Green Hygienics Holdings Inc. (OTCQB: GRYN) is a leader in high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, and they are dedicated to preserving and promoting the health of individuals, communities, and the planet. They also hold the distinction of being the first industrial hemp company in the U.S. to publish an Environmental, Social and Governance Report (“ESG Report”) using the Sustainability Accounting Standards Board (SASB) framework. Green Hygienics is well on their way to becoming the highest quality, and most sustainable hemp company out there.
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Ron Loudoun, CEO of Green Hygienics Holdings Inc.
The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s latest podcast features Ron Loudoun, CEO of Green Hygienics Holdings Inc. (OTCQB: GRYN) . Green Hygienics owns the largest single USDA certified organic hemp-for-CBD farm in North America. During the briefing, Loudoun highlighted last year’s milestones.
“It was a good year establishing ourselves at our new property. When you move into a new property, you have to find out what works best there as far as the pH and the soils and the water and what strain grows best,” he explained. “The property is an anomaly. It’s an 824-acre farm with 400,000 square feet of greenhouse. It’s an idyllic environment for the hemp plant. It’s an alpine meadow and an old lakebed. So, there’s nutrient-rich soil, nice altitude that cools down at night so the plant can have a chance to grow, because it grows at night. It has a nice gentle Santa Ana breeze to keep the buds dry, and lots and lots and lots of sunshine, so an extraordinary property and place to grow. We cultivated 120 acres last year and it turned out beautifully. We’ve proven out our ability to grow premium product there.” Loudoun then turned his attention to 2021 and the company’s plans for growth.
For 2021, we’ve made it a goal to double the cultivation area to 240 acres. We took advantage of fast-tracking our genetics division by acquiring the assets of a well-established consumer seed company that had trouble last year. We also bought the assets of Primordia, which is a cooperative in El Centro with up to 10,000 acres under growing contract, so it’s a booming start to 2021,” Loudoun said. “We’ve got an opportunity to add some cannabinoids in a controlled environment and grow them in the greenhouses. I think there is more and more of a market coming for that, and a lot of people don’t know how to cultivate it. These are cannabinoids that are coveted by the pharmaceutical, nutraceutical and medical markets, so it should be a very interesting year for us.”
Loudoun also discussed the buildout of targeted e-commerce websites, an important piece of the company’s strategy for direct-to-consumer sales.
Our objective is to have several e-commerce websites that market to specific target customers for each of those products. In dispensaries, they’re selling flower for $5 or $10 a gram,” he pointed out. “A pound has 453 grams. They come to the farm wanting to buy it for $250 a pound. Our product is USDA certified, in a class by itself. Why sell for $250 a pound when we can build a targeted e-commerce site and sell a pound for $4,500?”
Join InvestorBrandNetwork’s Stuart Smith and Ron Loudoun, CEO of Green Hygienics Holdings Inc. (OTCQB: GRYN) , to hear more about Green Hygienics’ business of hemp cultivation, Loudoun’s farming background and the company’s plans to get into hemp processing in addition to cultivation.
To hear the whole podcast and subscribe for future episodes, click here.
NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom.
Green Hygienics – An Industry Innovator
– Committed to Quality –
Green Hygienics is the largest single use USDA-Certified Organic hemp farm in North America. They grow the highest quality hemp possible on their 824-acre farm, which includes 400,000 square feet of greenhouse space, and they recently registered with the FDA. They are positioning themselves as an Organic, single-origin brand – perfect for high-end consumer markets and the pharmaceutical space.
– Intelligent Acquisitions–
With the acquisition of Primordia Assests and Castillo Seed Co., GRYN is solidifying their position as the best seed-to-consumer industrial hemp company in the industry. Along with the acquisitions come 100,000 acres of legacy farmland, unique high CBD seed, a built in consumer base, and more.
– Direct to Consumer –
GRYN is in the process of opening several e-commerce sites in order to sell their high-quality products directly to consumers. By skipping the middleman, Green Hygienics will be able to 10x their profit margins, while ensuring product quality and building a secure supply chain.
– Technological Edge –
Green Hygienics currently holds 4 patents, and is constantly innovating in the hemp space. With the acquisition of Castillo Seed Co, they now have access to a cutting-edge seed program, which will advance their own growing program significantly.
– Advancing Sustainability –
In order to adhere to their mission of promoting the health of individuals, communities, and the planet; GRYN is committed to using sustainable agriculture methods where possible, while exploring clean energy alternatives to power their pursuits.
Why Green Hygienics is a Unique Hemp Investment
High Revenue Potential – The Company’s uniquely organic offerings, ability to produce year round vis-à-vis indoor cultivation, combined with a recent push to sell DTC has positioned them to capitalize on market trends and maximize revenues.
Real Estate Backed –GRYN is a real estate-backed venture, with a (currently) $23M valuation of the 824 acre farm property. The recent acquisition of Primordia Assets adds access to 100,000 acres of legacy farmland to their real-estate portfolio.
Insulated from Shifting Regulations – In an effort to be ahead of the curve, GRYN has received USDA certified-organic status, registered with the FDA, and is a fully audited and SEC reporting company. As grow codes become stricter, we suspect regulators will not slow GRYN down.
Serving Multiple Markets –Multiple channels of distribution make GRYN a unique business model with the ability to target the underserved nutraceutical, medical, and pharmaceutical industries.
Favorable Stats – GRYN has less than 42 million shares outstanding, fully diluted. They have just 7.2 million in common shares in float and boasts a balance sheet with no toxic debt or overhang.
Passionate Leadership – The executive team has over 200 years combined experience in various sectors including biotech, agriculture, clean energy, sales, distribution, and have built multiple successful business. Each member is dedicated to improving the sustainability of the industry and the quality of their product.
A Unique Approach to Industrial Hemp
Green Hygienic Holdings Inc. (OTCQB: GRYN) is changing the way hemp growers operate. Their corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium quality products to consumers as well as to partnering with CPG (consumer-packaged-goods) and pharmaceutical companies.
They intend to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace, and have already obtained USDA Organic status and registered with the FDA.
The achievement of FDA registration strengthens our company’s core mission to provide product efficacy to the pharmaceutical industry and consumers alike,” said GRYN chief scientific officer Dr. Levan Darjania. “The company is well positioned to instill consumer confidence and change the landscape of the industry by bringing safe and consistent products to market. With our previously announced USDA Organic Certification and FDA Facility Registration, we are well positioned to continue to innovate through the research our teams are involved in and drive new commercial products entirely compliant to USDA and FDA regulatory requirements.”
Using state of the art technologies and strategic acquisitions, GRYN is opening up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration, and bioavailability.
Green Hygienics First ESG Report
Green Hygienics has continued to advance their efforts to be the most highly-certified, highest-quality hemp producer on the block. Most recently, they have become the first commercial hemp industry player to achieve the milestone of releasing an ESG Report using the SASB framework.
“Our financial and operational performance and key strategic objectives are dependent on our relationships and understanding our environmental impact. Our ESG Report will set key performance indicators and provide coherent information useful to our stakeholders,” states Ron Loudoun, CEO of Green Hygienics in a recent press release.
From the beginning, Green Hygienics has been committed to using the most environmentally friendly methods possible, while working with regulating bodies to ensure the safest, highest quality product, with the lowest impact on the land. They are on track to being Carbon Neutral by 2025, by offsetting and reducing their carbon footprint by acquiring greener technologies, using sustainable grow methods (such as drip irrigation, which reduces water consumption by up to 25%), and adopting energy saving practices.
They also participate in eco-friendly initiatives such as the Healthy Soils program, and have installed both beehives and owl nests at their farm property to help promote a sustainable local ecosystem.
In 2021, Green Hygienics conducted a materiality analysis in line with the SASB Standards to identify their core sustainability priorities. Every new project is subject to these standards and continued operations will only enhance their ability to improve upon performance. If Green Hygienics has a goal of being the most highly certified, safest, and most sustainable operation out there, we think they’re pretty darn close. And the ESG report certainly gets them even closer.
The diligence of Green Hygienics will pay off. ESG reporting is becoming more important by the day, with environmental concerns being the key driver. We can’t discount the social or governance pieces though. Obviously Green Hygienics is doing their part socially and environmentally by giving back to organizations and ensuring best environmental practices. In an age of scrutiny however, keeping tabs on governance and compliance is key. We think that Green Hygienics commitment to transparency and accountability will prove to be highly beneficial for them as they continue to grow. This report is a huge deal for any company, and we’re excited that Green Hygienics is a first mover in their industry.
Green Hygienics is seeking to provide their consumers best-in-class products, while expanding their operations in a sustainable way. This includes the targeted acquisition of existing companies (like Primordia Assets and Castillo Seed Co) that are in line with their own values, and securing a consistent supply chain for the development of high-grade nutraceuticals for underserved populations.
On the acquisition of Castillo Seed Co. and Primordia –
“We saw an opportunity to fast-track our genetics program by procuring a developed genetics portfolio which will not only save 3-5 years of R&D work but also allow the Company to propagate proprietary USDA Certified Organic seeds as soon as July of this year. USDA stamped seeds are a rare find and it just reaffirms our goal to becoming one of the most highly certified Hemp companies on the planet,” stated Kyle MacKinnon, COO. “Last year in 2020, we showed our ability to cultivate premium hemp and (recently) the Company acquired Primordia, which included 10,000 acres of legacy farming relationships and a multitude of other beneficial assets, including bulk wholesale finished product inventory. We are now entering a phase of rapid growth through acquisitions and continue to grow our own secure supply chain.”
These additions to GRYN’s portfolio will enhance their ability to produce quality products at scale, while maximizing their position as an organic producer of industrial hemp and pharmaceutical grade products.
The cannabis marketplace has been unpredictable. It can be difficult for companies to turn a profit in the grow space, partially due to inconsistent regulations among states.
As more states than ever pass legislation to legalize the growth and sale of hemp, the popular opinion is that when a state legalizes cannabis (in any way), it puts pressure on the surrounding states to do the same. Currently, cannabis is legal (to some degree) in all but 6 of the US states. As the economy continues to recover after the pandemic, companies expect the potential revenue created by legalization to tip the holdouts.
There is even a chance we’ll see full federal legalization soon.Analysts know that the potential market in the US is much bigger than in Canada (where several of the biggest marijuana players are), so companies based in the US are worth watching for the savvy investor.
Green Hygienics CEO Ron Loudoun speaks to the need for hemp companies to show success on their balance sheets in an interview with Randy Lennon. “(hemp companies need to) build a strong balance sheet, and demonstrate a profitable operation firstly in that space, because there aren’t a lot of people doing that right now.”
In a space where many companies are shutting down operations to save money, it’s easy to see why that is. Big producers like Canopy Growth (CGC) and Aurora Cannabis (ACB) have had to cut back drastically to keep money in the bank. Many Canadian companies are going to face price competition and market volatility in the coming months, as we slowly come out of the pandemic.
Green Hygienics focuses on unique growing methods and technologies that allow them to grow 24/7, with extreme control over the process. Their scientific approach puts them at an advantage in an unsure marketplace, especially as they begin to sell direct-to- consumer through their various e-commerce sites.
Ultimately, the full legalization of cannabis is inevitable, as the worldwide spending on cannabis is expected to triple by 2024, to the tune of $63.5 Billion dollars.This market is simply too big to ignore.
Who are we and what do we do?
We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (the “Information”) about publicly traded companies (the “Profiled Issuers”).
How is the Information published?
We publish the Information on our Website, in newsletters, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer or third party paying us.
Our publication of the Information is known as a “Campaign”.
Will everyone receive the Information at the same time?
No. The Information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart.
How is a potential investor impacted if he receives the Information later than other investors?
Typically, the trading volume and price of a Profiled Issuer’s securities increases after the Information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer increased trading losses if he purchases the securities of a Profiled Issuer.
What will happen to the shares that we hold during the Campaign?
We will sell the shares we hold while we tell investors to purchase during the Campaign.
What will happen when the Campaign ends?
Most, if not all, of the Profiled Issuers are penny stocks that are illiquid and whose securities are subject to wide fluctuations in trading price and volume. During the Campaign the trading volume and price of the securities of each Profiled Issuer will likely increase significantly. When the Campaign ends, the volume and price of the Profiled Issuer will likely decrease dramatically. As a result, investors who purchase during the Campaign and hold shares of the Profiled Issuer when the Campaign ends will probably lose most, if not all, of their investment.
Why do we publish only favorable Information?
We only publish favorable information because we are compensated to publish only favorable information.
Why don’t we publish negative Information?
We don’t publish negative information because we are not paid to publish negative information. We are paid to publish only favorable information.
Is the Information complete, accurate, truthful or reliable?
No. The Information is a snapshot that provides only positive information about the Profiled Issuers. The Information consists of only positive content. We do not and will not publish any negative information about the Profiled Issuers; accordingly, investors should consider the Information to be one-sided and not balanced, complete, accurate, truthful or reliable.
What we do not do?
We do not publish negative information about the Profiled Issuers. We do not verify or confirm any portion of the Information. We do not conduct any due diligence, nor do we research any aspect of the Information including the completeness, accuracy, truthfulness or reliability of the Information. We do not review the Profiled Issuers’ financial condition, operations, business model, management or risks involved in the Profiled Issuer’s business or an investment in a Profiled Issuer’s securities.
Where does the Information come from?
The Information is provided to us by the Profiled Issuers and/or the person who hires us. We may also obtain the Information from publicly available sources such as the OTC Markets, Google, NASDAQ, NYSE, the Securities and Exchange Commission’s Edgar database or other available public sources.
If we say we make “stock picks,” are those picks our own?
No, they are not. We are compensated to advertise the securities we are told to advertise.
What will happen if an investor relies on the Information?
If an investor relies on the Information in making an investment decision it is highly probable that the investor will lose most, if not all, of his or her investment. Investors should not rely on the Information to make an investment decision.
Who pays us to publish the Information?
The source of our compensation varies depending upon the particular circumstances of the Campaign. We are compensated by the Profiled Issuers, third party shareholders and other parties related to the Profiled Issuers such as officers and/or directors who will derive a financial or other benefit from an increase in the trading price and/or volume of a Profiled Issuer’s securities.
The nature and amount of compensation we receive for publishing the Information about each Profiled Issuer and our ownership of each Profiled Issuer is set forth below under the heading captioned, “What we are compensated”.
What warranties do we make about the Information?
None. We make no warranty or representation about the Information, including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable and as such, your use of the Information is at your own risk. The Information is provided as is without limitation.
What we are not.
We are not and do not act in the capacity of any of the following; as such, you should not construe our activities as involving any of the following:
An independent adviser or consultant;
A fortune teller;
An investment adviser or an entity engaging in activities that would be deemed to be providing investment advice that requires registration either at the federal or state level;
A broker-dealer or an individual acting in the capacity of a registered representative or broker;
A stock picker;
A securities trading expert;
A securities researcher or analyst;
A financial planner or one who engages in financial planning;
A provider of stock recommendations;
A provider of advice about buy, sell or hold recommendations as to specific securities; or
An agent offering or securities for sale or soliciting their purchase.
Are risks in this disclaimer the only risks investors should be aware of?
No. There are numerous risks associated with each Profiled Issuer and investors should undertake a full review of each Profiled Issuer with the assistance of their financial, legal, and tax advisers prior to purchasing the securities of any Profiled Issuer.
What conflicts of interest do we have in publishing the Information?
We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest.
What will happen to the shares that we hold during the Campaign?
We will sell the shares we hold while we tell investors to purchase.
Our publication of the Information involves actual and material conflicts of interest including but not limited to the following:
We receive monetary and/or securities compensation in exchange for publishing the (favorable) Information about the Profiled Issuers;
We do not publish any negative information whatsoever about the Profiled Issuers;
We may own a Profiled Issuer’s securities that we acquired from the Profiled Issuer, third parties or from our own open market purchases before, during or after the Campaign and we may sell these securities during the Campaign while publishing the (favorable) information that instructs investors to purchase. Our selling of a Profiled Issuer’s securities will likely cause investors to suffer losses;
A short time after we acquire a Profiled Issuer’s securities, we may publish the (favorable) Information about the Profiled Issuer advising others, including you, to purchase; and while doing so, we may sell the Profiled Issuer’s securities we acquired during our public dissemination of the Information causing us to profit while you suffer a loss;
Parties holding a Profiled Issuer’s securities, including those who engage our services and/or compensate us, will sell their shares of the Profiled Issuer while we are publishing the (favorable) Information.
Who is responsible if an investor relies on the Information?
The investor. We are not responsible or liable for any person’s use of the Information or any success or failure that is directly or indirectly related to such person’s use of the Information because we have specifically stated that the information is not reliable and should not be relied upon for any purpose. We are not responsible for omissions or errors in the Information, and we are not responsible for actions taken by any person who relies upon the Information.
What do we urge potential investors to do?
We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and investment advisers. An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. An investor’s review should include, but not be limited to a review of available public sources and information received directly from the Profiled Issuers or from websites such as Google, OTC Markets, NASDAQ, NYSE, www.sec.gov or other available public sources.
Why is this Disclaimer being provided?
We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate the Information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose our compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a Profiled Issuer before, during and after we publish favorable Information about the Profiled Issuer. We may urge investors to purchase the securities of a Profiled Issuer while we sell our own shares.
The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of Profiled Issuer’s securities before, during and after the Campaigns.What are other risks that investors should be aware of?
Any investment in the Profiled Issuers involves a high degree of risk and uncertainty. The securities may be subject to extreme volume and price volatility, especially during the Campaigns. Favorable past performance of a Profiled Issuer does not guarantee future results. If you purchase the securities of the Profiled Issuers, you should be prepared to lose your entire investment. Some of the risks involved in purchasing securities of the Profiled Issuers include, but are not limited to the risks stated below.
We do not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information. We conduct no due diligence or investigation whatsoever of the Information or the Profiled Issuers and we do not receive any verification from the Profiled Issuer regarding the Information we disseminate.
If we publish any percentage gain of a Profiled Issuer from the previous day close in the Information, it is not and should not be construed as an indication that the future stock price or future operational results will reflect gains or otherwise prove to be advantageous to your investment.
The Information may contain statements asserting that a Profiled Issuer’s stock price has increased over a certain period of time which may reflect an arbitrary period of time, and is not predictive or of any analytical quality; as such, you should not rely upon the (favorable) Information in your analysis of the present or future potential of a Profiled Issuer or its securities.
The Information should not be interpreted in any way, shape, form or manner whatsoever as an indication of the Profiled Issuer’s future stock price or future financial performance.
You may encounter difficulties determining what, if any, portions of the Information are material or non-material, making it all the more imperative that you conduct your own independent investigation of the Profiled Issuer and its securities with the assistance of your legal, tax and financial advisor.
We or other stock promoters may receive free trading shares as compensation or we may acquire such shares in open market transactions before and during the Campaigns, and we may sell the shares we acquire at any time, even during the Campaigns while publishing the Favorable Information. When we sell the shares of the Profiled Issuers that we hold, the price at which investors can sell their shares will dramatically decrease and will likely cause investors to suffer trading losses.
We may sell securities of the Profiled Issuers for less than target prices set forth in the Information, and we may profit by selling our securities during the Campaigns while investors encounter losses.
When we acquire, purchase or sell the securities of the Profiled Issuers, it may (a) cause significant volatility in the Profiled Issuer’s securities; (b) cause temporary but unrealistic increases in volume and price of the Profiled Issuer’s securities; (c) if selling, cause the Profiled Issuer’s stock price to decline dramatically; and (d) permit us to make substantial profits while investors who purchase during the Campaign experience significant losses.
The securities of the Profiled Issuers are high risk, unstable, unpredictable and illiquid which may make it difficult for investors to sell their securities of the Profiled Issuers.
If we are compensated in improperly free trading securities of the Profiled Issuers, either directly or indirectly from persons who claim to be non-affiliates of such Profiled Issuer, we and the Profiled Issuer or third party could be subject to SEC Enforcement Action, including allegations of an illegal distribution in violation of Section 5(a) and 5(c) of the Securities Act.
We may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer and fail to disclose their compensation to you.
If a Profiled Issuer is an SEC reporting company, it could be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports), or if it is an OTC Markets Pink Sheet quoted company, it may be delinquent in its Pink Sheet reporting obligations, which may result in OTC Markets posting a negative legend pertaining to the Profiled Issuer at www.otcmarkets.com, as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “No Information,” which characterizes companies that are unable or unwilling to provide any disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor,” signifying buyers should be aware that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions.
If the Information states that a Profiled Issuer’s securities are consistent with the future economic trends or even if your independent research indicates that, you should be aware that economic trends have their own limitations, including: (a) that economic trends or predictions may be speculative; (b) consumers, producers, investors, borrowers, lenders and government may react in unforeseen ways and be affected by behavioral biases that we are unable to predict; (c) human and social factors may outweigh future economic trends that we state may or will occur; (d) clear cut economic predictions have their limitations in that they do not account for the fundamental uncertainty in economic life, as well as ordinary life; (e) economic trends may be disrupted by sudden jumps, disruptions or other factors that are not accounted for in economic trends analysis; in other words, past or present data predicting future economic trends may become irrelevant in light of new circumstances and situations in which uncertainty becomes reality rather than predicted economic outcome; or (f) if the trend predicted involves a single result, it ignores other scenarios that may be crucial to make a decision in the event of unknown contingencies.
The Information is presented only as a brief snapshot of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities. You should consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.govwww.sec.gov, www.otcmarkets.com or other electronic media, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the OTCMarkets.com; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.org. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and the OTC Markets and/or have negative legends and designations at otcmarkets.com.
What we were paid to advertise the Profiled Issuers.
The details of our compensation and the period of the Campaign is set forth below.
Name of Issuer & Ticker Symbol - Green Hygienics (GRYN)
Amount & Form of Compensation - $500,000.00 in Common Stock
Who Paid for the Campaign & Position with Company if any - Green Hygienics (GRYN)
Period of Campaign - August 31st 2020 to August 31st 2021
What securities of the Profiled Issuers do we hold?
The positions we hold of the Profiled Issuer are set forth below. We plan to sell these securities during the Campaign.
Name of Issuer & Ticker Symbol - Green Hygienics (GRYN)
Number of Shares We or our Affiliates Hold - 500,000.00
. To find out more, read our